Elizabeth Macintyre
Overview
Explore the profile of Elizabeth Macintyre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
5908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karlsen T, Murray F, Filippidis F, Meijer M, Jha P, Waldemar G, et al.
Lancet Reg Health Eur
. 2025 Mar;
50:101244.
PMID: 40070720
No abstract available.
2.
Fedoriw Y, Silva O, Znaor A, Macintyre E
Histopathology
. 2024 Oct;
86(1):6-16.
PMID: 39420576
The accurate diagnosis of haematolymphoid malignancies is crucial for effective cancer care, but major obstacles to diagnosis exist in low- and middle-income countries (LMICs). This article explores the global applicability...
3.
Latiri M, Belhocine M, Smith C, Garnier N, Balducci E, Pinton A, et al.
J Pathol
. 2024 Sep;
264(3):284-292.
PMID: 39329449
T-lymphoblastic lymphoma (T-LBL) and thymoma are two rare primary tumors of the thymus deriving either from T-cell precursors or from thymic epithelial cells, respectively. Some thymoma subtypes (AB, B1, and...
4.
Plebani M, Cadamuro J, Vermeersch P, Jovicic S, Ozben T, Trenti T, et al.
Clin Chem Lab Med
. 2024 Sep;
62(12):2373-2387.
PMID: 39259894
The ultimate goal of value-based laboratory medicine is maximizing the effectiveness of laboratory tests in improving patient outcomes, optimizing resources and minimizing unnecessary costs. This approach abandons the oversimplified notion...
5.
Simonin M, Vasseur L, Lengline E, Lhermitte L, Cabannes-Hamy A, Balsat M, et al.
Blood
. 2024 Jun;
144(15):1570-1580.
PMID: 38848537
We previously reported a better outcome in adult and pediatric T-cell acute lymphoblastic leukemia (T-ALL) harboring NOTCH1 and/or FBXW7 mutations without alterations of K-N-RAS and PTEN genes. Availability of high-throughput...
6.
Sarkozy C, Callanan M, Thieblemont C, Oberic L, Burroni B, Bouabdallah K, et al.
Blood
. 2024 Apr;
144(3):262-271.
PMID: 38669626
Obinutuzumab (O) and rituximab (R) are 2 CD antibodies that have never been compared in a prospective randomized trial of mantle cell lymphoma (MCL). Herein, we report the long-term outcome...
7.
Kroeze E, Iaccarino I, Kleisman M, Mondal M, Beder T, Khouja M, et al.
Blood
. 2024 Apr;
144(1):74-83.
PMID: 38588489
Pediatric B-cell precursor (BCP) lymphoblastic malignancies are neoplasms with manifestation either in the bone marrow or blood (BCP acute lymphoblastic leukemia [BCP-ALL]) or are less common in extramedullary tissue (BCP...
8.
Macintyre E, Dohner K, Gronbaek K, Dreyling M, Huntly B, Almeida A, et al.
Hemasphere
. 2024 Apr;
8(4):e65.
PMID: 38577479
No abstract available.
9.
Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL
Balducci E, Simonin M, Duployez N, Steimle T, Dourthe M, Villarese P, et al.
Blood
. 2024 Mar;
144(9):988-1000.
PMID: 38518104
Given the poor outcome of refractory and relapsing T-cell acute lymphoblastic leukemia (T-ALL), identifying prognostic markers is still challenging. Using single nucleotide polymorphism (SNP) array analysis, we provide a comprehensive...
10.
Hoster E, Delfau-Larue M, Macintyre E, Jiang L, Stilgenbauer S, Vehling-Kaiser U, et al.
J Clin Oncol
. 2023 Nov;
42(5):538-549.
PMID: 37992261
Purpose: The outcome of older patients with mantle cell lymphoma (MCL) has improved by the introduction of immunochemotherapy, followed by rituximab (R)-maintenance. Assessment of minimal residual disease (MRD) represents a...